Clinical Trial Update: An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria [Phase 3]

View source ↗

Summary

An extension study of Oxabact in primary hyperoxaluria (Phase 3) has been terminated; results posted in 2021. Long-term efficacy and safety data are reported fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria

Drugs mentioned

• Oxabact

Snippet

Sponsor: OxThera | Conditions: Hyperoxaluria, Primary | Phase 3 | Status: TERMINATED | Results posted: 2021-12-08